Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/8/2026

Cocaine Withdrawal Management

Evidence-Based Treatment Approach

  • The American Family Physician recommends that no pharmacologic treatment for cocaine withdrawal can be recommended for use in clinical practice, due to lack of evidence 1, 2
  • The combination of Contingency Management (CM) plus Community Reinforcement Approach (CRA) is the most effective treatment for cocaine withdrawal and dependence, with a number needed to treat (NNT) of 3.7 (95% CI 2.4–14.2), as suggested by guidelines 3
  • Contingency Management provides tangible rewards contingent upon drug-free urine samples, creating immediate positive reinforcement for abstinence, which is a key component of effective treatment 3, 4
  • Community Reinforcement Approach addresses underlying psychological and social factors through functional analysis, coping-skills training, and social/familial/recreational/vocational reinforcements, providing sustained support for long-term recovery 3, 4

Symptomatic Management

  • Withdrawal from cocaine is best undertaken in a supportive environment with symptomatic medication only for relief of specific symptoms, such as agitation, sleep disturbance, or other symptoms, as recommended by PLoS Medicine 5
  • The PLoS Medicine guidelines suggest treating agitation with appropriate sedatives as needed, and sleep disturbance with appropriate sleep aids as needed 5
  • Monitoring for depression or psychosis during withdrawal is crucial, as these conditions require close monitoring and specialist consultation if they develop 5

Treatment Implementation

  • The initial assessment and withdrawal management should be conducted in a supportive environment with regular monitoring, and symptomatic medications should be provided only for specific symptoms 5
  • Implementing CM plus CRA immediately upon patient presentation is recommended as first-line treatment, with regular urine drug screening to provide objective evidence for CM rewards 3
  • Cognitive Behavioral Therapy (CBT) alone can be considered as second-line treatment, though it is more acceptable than treatment as usual but not significantly more efficacious for abstinence 3, 6

Critical Pitfalls to Avoid

  • The American Family Physician guidelines advise against prescribing medications as primary treatment for cocaine withdrawal or dependence 1, 2
  • Using CM without CRA or similar comprehensive approaches can lead to relapse after treatment completion 3, 4
  • Failing to provide long-term follow-up is a critical pitfall, as it is essential for sustained recovery 3, 4

Special Considerations

  • For patients with comorbid psychiatric disorders, ensuring psychiatric consultation is available is crucial, as these patients may require specialized management 6
  • Addressing barriers such as lack of motivation and facilitating access to sterile injection equipment and outreach programs is important for individuals who inject cocaine 5, 3

Evidence‑Based Management of Cocaine Withdrawal and Dependence

Withdrawal Symptom Management

  • Conduct withdrawal in a supportive environment and use symptomatic medications only for agitation or insomnia; no specific drug is recommended for treating cocaine withdrawal itself. 7
  • Provide sedatives as needed for agitation and sleep aids for insomnia during the acute withdrawal period. 7
  • Monitor closely for emergence of depression or psychosis during withdrawal and obtain specialist consultation if these complications develop. 7

Cardiovascular Assessment

  • Screen all patients for cardiovascular complications (e.g., coronary spasm, tachycardia, hypertension) because even small amounts of cocaine can precipitate these events. 8

Psychosocial Interventions

Contingency Management (CM) Component

  • Apply escalating reinforcement (increasing rewards) for consecutive weeks of abstinence rather than flat rewards to strengthen abstinence reinforcement. 9

Brief Psychosocial Intervention

  • Offer a single brief session (approximately 5–30 minutes) that provides individualized feedback and advice on reducing or stopping cocaine use. 7

Motivational Interviewing

  • Use open‑ended, non‑confrontational questions to explore the patient’s knowledge of cocaine’s health effects, elicit personal concerns and goals, and provide tailored risk information. 8

Pharmacologic Recommendations

  • Do not prescribe any medication as primary treatment for cocaine withdrawal or dependence; current evidence does not support a pharmacologic regimen. 8
  • Specifically avoid dexamphetamine for the treatment of stimulant‑use disorders. 7

Referral and Follow‑Up

  • Refer patients who do not respond to brief psychosocial interventions to a specialist for further assessment and management. 7

Treatment Duration and Relapse Prevention

  • Short, rapid‑taper treatment courses are linked to high relapse rates; longer‑term maintenance strategies are generally indicated to sustain recovery. 8
  • Limiting psychosocial interventions only to individuals whose goal is complete abstinence is ineffective; reductions in the amount or frequency of use also confer important health benefits. 8

Special Populations

  • For patients who inject cocaine, ensure access to sterile injection equipment and community outreach programs to reduce injection‑related harms. 7
  • Involve family members in the treatment process when appropriate and provide support resources for families themselves. 7